Clinical Trial Update: Pulmonary Fibrosis After Severe COVID-19 Pneumonia

View source ↗

Summary

A completed clinical trial (NCT06423560) evaluating pulmonary fibrosis after severe COVID-19 pneumonia has finished.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Pulmonary Fibrosis, COVID-19 | Status: COMPLETED